Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published May 1989

Interleukin 1 Protects against the Lethal Effects of Irradiation of Mice but has No Effect on Tumors in the Same Animals

Abstract

Interleukin 1 (IL-1) is a radioprotector of bone marrow and is cytotoxic to some tumor cells. This investigation examines these two properties in the same host animals and gives evidence of radioprotection against localized x-irradiation of the head and neck region. By LD50 analyses, recombinant human IL-1 (100 ng/mouse, approximately 3 μg/kg) was found to be radioprotective against whole-body irradiation for both C3H/Km and C57BL/Ka mice. The combined potency ratio for the two strains was 1.07 (95% confidence limit: 1.02–1.12). It was also radioprotective against the injury leading to acute lethality resulting from localized head and neck irradiation of C3H/Km mice; 100 ng of IL-1/mouse produced a potency ratio of 1.05 (95 confidence limit: 1.03–1.07). However, two tumors that originated in C3H/Km mice, RIF-1 and SCCVII, showed neither in vitro nor in vivo response to IL-1. Also, there was no IL-1-induced reduction in in vivo growth of the RL 12NP lymphoma in C57BL/Ka mice.

Get full access to this article

View all access and purchase options for this article.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published: May 1989
Issue published: May 1989

Authors

Affiliations

Mohamed S. Zaghloul1
Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305 and Department of Immunology Syntex Research, Palo Alto, California 94304

Notes

Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305 and Department of Immunology
1
Present address: Radiotherapy Department, National Cancer Institute, Cairo University, foum El Khalig, Cairo, Egypt.

Metrics and citations

Metrics

Journals metrics

This article was published in Experimental Biology and Medicine.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 2

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 0

Crossref: 6

  1. Appraisal of biochemical classes of radioprotectors: evidence, current...
    Go to citation Crossref Google Scholar
  2. Elevating body temperature enhances hematopoiesis and neutrophil recov...
    Go to citation Crossref Google Scholar
  3. Time‐ and dose‐dependent changes of intracellular cytokine and cytokin...
    Go to citation Crossref Google Scholar
  4. Enhancement of the Radiation Response with Interleukins and Interferon...
    Go to citation Crossref Google Scholar
  5. Interleukin‐Iß plasma levels decrease following local radiation therap...
    Go to citation Crossref Google Scholar
  6. On Radiation Damage to Normal Tissues and its Treatment: I. Growth fac...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

SEBM members can access this journal content using society membership credentials.

SEBM members can access this journal content using society membership credentials.


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub